Clinical trial PRIMMO trial - Pembrolizumab-Radiotherapy-Immunomodulator trial
A phase II Investigation of Pembrolizumab (Keytruda) in combination with radiation and an immune modulatory cocktail in patients with cervical and uterine cancer
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | UZ-Gent |
| EudraCT Identifier | 2016-001569-97 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03192059 |
| Inclusion criteria | after one line |
| Last update |